{{Rsnum
|rsid=11568564
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=12
|Orientation=minus
|Gene=SLCO1A2
|position=21304514
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=SLCO1A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 99.1 | 0.9 | 0.0
| HCB | 98.5 | 1.5 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 98.6 | 1.4 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 97.2 | 2.8 | 0.0
| MEX | 94.8 | 5.2 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11568564
|Name_s=SLCO1A2: R168C
|Gene_s=SLCO1A2
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Reduced uptake of estrone sulfate and methotrexate in oocytes
|Drugs=conjugated estrogens; methotrexate
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111594
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}